This study is currently not recruiting participants.

A Randomized Open-Label Trial of Caspofungin vs. Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)

Investigating the Effectiveness of an Investigational Antifungal Medication

Not Recruiting
18 years or below
All
Phase N/A

Brief description of study.

In this study, researchers want to find out if using a newer antifungal drug called caspofungin (also called Cancidas?) will be better than the current standard antifungal drug fluconazole at preventing invasive fungal infections when given to people with

Detailed description of study

In this study, researchers want to find out if using a newer antifungal drug called caspofungin (also called Cancidas?) will be better than the current standard antifungal drug fluconazole at preventing invasive fungal infections when given to people with

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acute Myeloid Leukemia
  • Age: 18 years or below
  • Gender: All

This study investigates the effectiveness of an investigational antifungal medication compared to a standard antifungal drug in preventing invasive fungal infections. Invasive fungal infections occur when fungi invade the body, which can be serious and require medical attention.

Participants in the study will receive either the investigational antifungal medication or the standard antifungal drug. The study will monitor the effectiveness of these medications in preventing infections.

  • Who can participate: Eligibility criteria include age requirements and other key factors, which should be specified.
  • Study details: Participants will be randomly assigned to receive either the investigational antifungal medication or the standard antifungal drug. The study will compare their effectiveness in preventing infections.
Updated on 19 Feb 2024. Study ID: 1007006317

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team